Clinical Trial Results: A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight [Phase 1]

View source ↗

Summary

Phase 1 trial comparing tablet and capsule forms of Orforglipron (LY3502970) in healthy overweight/obese participants; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Obese | Phase 1 | Status: COMPLETED | Results posted: 2026-07-17